ALUR
Allurion Technologies Inc.
Price Chart
Latest Quote
$0.85
+0.13 (+17.28%)
Current Price
| Previous Close | $0.73 |
| Open | $0.67 |
| Day High | $0.85 |
| Day Low | $0.67 |
| Volume | 38,826 |
Stock Information
| Shares Outstanding | 15.01M |
| Total Debt | $78.25M |
| Cash Equivalents | $5.06M |
| Revenue | $12.60M |
| Net Income | $-33.35M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $12.83M |
| EPS (TTM) | $-3.96 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $86.02M |
| Sales | $12.60M |
| Income | $-33.35M |
| Book/sh | $-5.20 |
| Cash/sh | $0.34 |
| Employees | 38 |
Financial Ratios
| Quick Ratio | 0.23 |
| Current Ratio | 0.30 |
Returns & Margins
| ROA | -66.80% |
| Gross Margin | 52.70% |
| Operating Margin | -126.60% |
| Profit Margin | -264.74% |
Ownership
| Insider Ownership | 5.18% |
| Institutional Ownership | 1.18% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.69 |
| P/S | 1.02 |
| P/B | -0.16 |
Analyst Data
| Recommendation | none |
| Target Price | $5.50 |
Technical Indicators
| SMA20 | $0.78 |
| SMA50 | $0.77 |
| SMA200 | $1.38 |
| RSI | 58.06 |
| ATR | 0.1701 |
| Shares Float | 14.70M |
| Short Float | 5.17% |
| Short Ratio | 4.91 |
| Volatility | -0.21 |
| Rel Volume | 0.93 |
Performance History
| Week | +6.88% |
| Month | +8.37% |
| Quarter | +12.65% |
| 6 Months | -41.44% |
| YTD | -41.03% |
| Year | -68.57% |
| 3 Years | -99.67% |
| 5 Years | -99.65% |
| 10 Years | -99.65% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-03 | $0.86 | 47,200 |
| 2026-06-02 | $0.73 | 19,000 |
| 2026-06-01 | $0.67 | 31,300 |
| 2026-05-29 | $0.71 | 31,900 |
| 2026-05-28 | $0.69 | 219,900 |
| 2026-05-27 | $0.80 | 7,700 |
| 2026-05-26 | $0.80 | 24,100 |
| 2026-05-22 | $0.83 | 8,200 |
| 2026-05-21 | $0.79 | 14,400 |
| 2026-05-20 | $0.85 | 15,100 |
| 2026-05-19 | $0.91 | 6,400 |
| 2026-05-18 | $0.91 | 7,700 |
| 2026-05-15 | $0.85 | 43,200 |
| 2026-05-14 | $0.95 | 447,200 |
| 2026-05-13 | $0.70 | 13,000 |
| 2026-05-12 | $0.80 | 6,000 |
| 2026-05-11 | $0.71 | 16,800 |
| 2026-05-08 | $0.78 | 21,600 |
| 2026-05-07 | $0.68 | 16,200 |
| 2026-05-06 | $0.68 | 18,100 |
| 2026-05-05 | $0.69 | 35,800 |
| 2026-05-04 | $0.79 | 6,000 |
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
đ° Latest News
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
Zacks âĸ 2026-02-27T14:40:03Z
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
Zacks âĸ 2025-11-18T09:01:00Z
4 Medical Product Stocks to Watch From a Challenging Industry
Zacks âĸ 2025-11-17T14:20:00Z
Allurion Technologies Inc. Q3 2025 Earnings Call Summary
Moby âĸ 2025-11-13T13:30:00Z
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Call Highlights: Strategic Restructuring and ...
GuruFocus.com âĸ 2025-11-12T21:04:06ZAllurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates
Zacks âĸ 2025-08-19T22:40:02Z
Allurion Technologies Inc (ALUR) Q2 2025 Earnings Call Highlights: Strategic Pivot and Cost ...
GuruFocus.com âĸ 2025-08-14T07:08:33ZBioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
Zacks âĸ 2025-08-07T21:20:01Z
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
Zacks âĸ 2025-08-01T21:15:01Z
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
Zacks âĸ 2025-07-31T21:35:05Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $10,607,000 | $11,970,000 | $13,485,000 | $9,052,000 |
| Cost Of Revenue | $10,607,000 | $11,970,000 | $13,485,000 | $9,052,000 |
| Total Revenue | $32,110,000 | $53,467,000 | $64,211,000 | $38,242,000 |
| Operating Revenue | $32,110,000 | $53,467,000 | $64,211,000 | $38,242,000 |
| Expenses | ||||
| Interest Expense | $2,264,000 | $10,566,000 | $4,426,000 | $3,668,000 |
| Total Expenses | $82,308,000 | $132,545,000 | $96,221,000 | $50,743,000 |
| Other Income Expense | $45,982,000 | $7,091,000 | $-1,165,000 | $3,783,000 |
| Other Non Operating Income Expenses | $19,542,000 | $-4,394,000 | $-344,000 | $-555,000 |
| Net Non Operating Interest Income Expense | $-2,264,000 | $-10,566,000 | $-4,426,000 | $-3,668,000 |
| Interest Expense Non Operating | $2,264,000 | $10,566,000 | $4,426,000 | $3,668,000 |
| Operating Expense | $71,701,000 | $120,575,000 | $82,736,000 | $41,691,000 |
| Selling And Marketing Expense | $25,933,000 | $46,857,000 | $50,405,000 | $27,144,000 |
| General And Administrative Expense | $28,399,000 | $46,024,000 | $15,365,000 | $8,818,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Net Interest Income | $-2,264,000 | $-10,566,000 | $-4,426,000 | $-3,668,000 |
| Normalized Income | $-28,085,600 | $-91,890,150 | $-37,095,410 | $-16,724,000 |
| Net Income From Continuing And Discontinued Operation | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Total Operating Income As Reported | $-50,198,000 | $-79,078,000 | $-32,010,000 | $-12,501,000 |
| Net Income Common Stockholders | $-7,198,000 | $-84,514,000 | $-40,651,000 | $-13,626,000 |
| Net Income | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Net Income Including Noncontrolling Interests | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Net Income Continuous Operations | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Pretax Income | $-6,480,000 | $-82,553,000 | $-37,601,000 | $-12,386,000 |
| Special Income Charges | $14,187,000 | $7,523,000 | $0 | $4,375,000 |
| Operating Income | $-50,198,000 | $-79,078,000 | $-32,010,000 | $-12,501,000 |
| Gross Profit | $21,503,000 | $41,497,000 | $50,726,000 | $29,190,000 |
| Per Share | ||||
| Diluted EPS | $-11.64 | $-57.75 | $-21.85 | $-7.33 |
| Basic EPS | $-11.64 | $-57.75 | $-21.85 | $-7.33 |
| Other | ||||
| Tax Effect Of Unusual Items | $5,552,400 | $2,411,850 | $-172,410 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-29,910,000 | $-82,726,000 | $-31,459,000 | $-12,349,000 |
| Total Unusual Items | $26,440,000 | $11,485,000 | $-821,000 | $4,338,000 |
| Total Unusual Items Excluding Goodwill | $26,440,000 | $11,485,000 | $-821,000 | $4,338,000 |
| Reconciled Depreciation | $746,000 | $746,000 | $895,000 | $707,000 |
| EBITDA (Bullshit earnings) | $-3,470,000 | $-71,241,000 | $-32,280,000 | $-8,011,000 |
| EBIT | $-4,216,000 | $-71,987,000 | $-33,175,000 | $-8,718,000 |
| Diluted Average Shares | $2,247,164 | $1,423,266 | $1,860,080 | $1,860,080 |
| Basic Average Shares | $2,247,164 | $1,423,266 | $1,860,080 | $1,860,080 |
| Diluted NI Availto Com Stockholders | $-7,198,000 | $-84,514,000 | $-40,651,000 | $-13,626,000 |
| Tax Provision | $718,000 | $264,000 | $143,000 | $0 |
| Other Special Charges | $8,713,000 | $21,527,000 | - | $-4,375,000 |
| Restructuring And Mergern Acquisition | $-22,900,000 | $-29,050,000 | $0 | - |
| Gain On Sale Of Security | $12,253,000 | $3,962,000 | $-821,000 | $-37,000 |
| Research And Development | $17,369,000 | $27,694,000 | $16,966,000 | $5,729,000 |
| Selling General And Administration | $54,332,000 | $92,881,000 | $65,770,000 | $35,962,000 |
| Other Gand A | $28,399,000 | $46,024,000 | $15,365,000 | $8,818,000 |
| Preferred Stock Dividends | - | $1,697,000 | $2,907,000 | $1,240,000 |
Fetched: 2026-03-06
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-34,285,000 |
| Total Assets | $32,813,000 | $71,712,000 | $51,370,000 | $39,351,000 |
| Total Non Current Assets | $5,657,000 | $6,896,000 | $7,987,000 | $2,025,000 |
| Other Non Current Assets | $1,109,000 | $505,000 | $2,706,000 | $311,000 |
| Current Assets | $27,156,000 | $64,816,000 | $43,383,000 | $37,326,000 |
| Other Current Assets | $1,243,000 | $2,414,000 | $2,487,000 | $1,936,000 |
| Inventory | $3,400,000 | $6,171,000 | $3,865,000 | $2,715,000 |
| Receivables | $7,134,000 | $18,194,000 | $29,346,000 | $6,832,000 |
| Accounts Receivable | $7,134,000 | $18,194,000 | $29,346,000 | $6,832,000 |
| Allowance For Doubtful Accounts Receivable | $-6,701,000 | $-12,671,000 | $-741,000 | $-354,000 |
| Gross Accounts Receivable | $13,835,000 | $30,865,000 | $30,087,000 | $7,186,000 |
| Cash Cash Equivalents And Short Term Investments | $15,379,000 | $38,037,000 | $7,685,000 | $25,843,000 |
| Cash And Cash Equivalents | $15,379,000 | $38,037,000 | $7,685,000 | $25,843,000 |
| Debt | ||||
| Net Debt | $20,331,000 | $606,000 | $48,778,000 | $300,000 |
| Total Debt | $37,923,000 | $41,857,000 | $59,531,000 | $26,143,000 |
| Long Term Debt And Capital Lease Obligation | $37,054,000 | $2,306,000 | $5,266,000 | $2,003,000 |
| Long Term Debt | $35,710,000 | - | $3,103,000 | $2,003,000 |
| Current Debt And Capital Lease Obligation | $869,000 | $39,551,000 | $54,265,000 | $24,140,000 |
| Current Debt | - | $38,643,000 | $53,360,000 | $24,140,000 |
| Other Current Borrowings | - | $38,643,000 | $53,360,000 | $24,140,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $110,791,000 | $143,009,000 | $83,684,000 | $73,636,000 |
| Total Non Current Liabilities Net Minority Interest | $91,928,000 | $77,584,000 | $7,817,000 | $42,025,000 |
| Other Non Current Liabilities | $50,307,000 | $68,513,000 | $2,551,000 | $900,000 |
| Derivative Product Liabilities | $4,567,000 | $6,765,000 | $0 | - |
| Current Liabilities | $18,863,000 | $65,425,000 | $75,867,000 | $31,611,000 |
| Payables And Accrued Expenses | $16,948,000 | $24,187,000 | $18,149,000 | $5,042,000 |
| Payables | $6,572,000 | $10,379,000 | $5,809,000 | $1,618,000 |
| Accounts Payable | $6,572,000 | $10,379,000 | $5,809,000 | $1,618,000 |
| Interest Payable | - | $0 | $489,000 | $0 |
| Current Deferred Liabilities | - | - | $0 | $202,000 |
| Equity | ||||
| Common Stock Equity | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-92,258,000 |
| Total Equity Gross Minority Interest | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-34,285,000 |
| Stockholders Equity | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-34,285,000 |
| Gains Losses Not Affecting Retained Earnings | $-8,370,000 | $700,000 | $0 | - |
| Other Equity Adjustments | $-8,370,000 | $700,000 | - | - |
| Retained Earnings | $-222,207,000 | $-215,009,000 | $-132,192,000 | $-94,448,000 |
| Preferred Stock Equity | - | - | $57,999,000 | $57,973,000 |
| Preferred Securities Outside Stock Equity | - | - | $39,122,000 | $39,122,000 |
| Other | ||||
| Ordinary Shares Number | $2,710,607 | $1,907,523 | $1,860,080 | $1,860,080 |
| Share Issued | $2,710,607 | $1,907,523 | $1,860,080 | $1,860,080 |
| Tangible Book Value | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-92,258,000 |
| Invested Capital | $-42,268,000 | $-32,654,000 | $24,149,000 | $-66,115,000 |
| Working Capital | $8,293,000 | $-609,000 | $-32,484,000 | $5,715,000 |
| Capital Lease Obligations | $2,213,000 | $3,214,000 | $3,068,000 | $0 |
| Total Capitalization | $-42,268,000 | $-71,297,000 | $-29,211,000 | $-32,282,000 |
| Additional Paid In Capital | $152,596,000 | $143,010,000 | $99,877,000 | $2,139,000 |
| Capital Stock | $3,000 | $2,000 | $1,000 | $58,024,000 |
| Common Stock | $3,000 | $2,000 | $1,000 | $51,000 |
| Preferred Stock | $0 | $0 | $0 | $57,973,000 |
| Long Term Capital Lease Obligation | $1,344,000 | $2,306,000 | $2,163,000 | $0 |
| Current Capital Lease Obligation | $869,000 | $908,000 | $905,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,046,000 | $1,687,000 | $3,453,000 | $2,227,000 |
| Current Accrued Expenses | $10,376,000 | $13,808,000 | $12,340,000 | $3,424,000 |
| Net PPE | $4,548,000 | $6,391,000 | $5,281,000 | $1,714,000 |
| Accumulated Depreciation | $-4,357,000 | $-3,559,000 | $-2,851,000 | $-1,987,000 |
| Gross PPE | $8,905,000 | $9,950,000 | $8,132,000 | $3,701,000 |
| Leases | $1,943,000 | $1,943,000 | $1,822,000 | $1,755,000 |
| Construction In Progress | $14,000 | $1,195,000 | $583,000 | $13,000 |
| Other Properties | $2,079,000 | $3,010,000 | $2,899,000 | - |
| Machinery Furniture Equipment | $4,869,000 | $3,802,000 | $2,828,000 | $1,933,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,789,000 | $3,427,000 | $2,096,000 | $1,609,000 |
| Work In Process | $763,000 | $967,000 | $213,000 | $216,000 |
| Raw Materials | $848,000 | $1,777,000 | $1,556,000 | $890,000 |
| Current Deferred Revenue | - | - | $0 | $202,000 |
Fetched: 2026-03-06
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-65,588,000 | $-65,588,000 | $-48,531,000 | $-15,241,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-63,982,000 | $-63,982,000 | $-46,981,000 | $-14,329,000 |
| Cash Flow From Continuing Operating Activities | $-63,982,000 | $-63,982,000 | $-46,981,000 | $-14,329,000 |
| Operating Gains Losses | $-693,000 | $-2,885,000 | $726,000 | $-1,367,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Investing Cash Flow | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Cash Flow From Continuing Investing Activities | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $0 | $9,871,000 |
| Financing Cash Flow | $95,986,000 | $95,986,000 | $30,537,000 | $28,945,000 |
| Cash Flow From Continuing Financing Activities | $95,986,000 | $95,986,000 | $30,537,000 | $28,945,000 |
| Net Other Financing Charges | $95,702,000 | $95,702,000 | $-548,000 | $-522,000 |
| Net Common Stock Issuance | $0 | $0 | - | - |
| Common Stock Issuance | $0 | $0 | - | - |
| Net Preferred Stock Issuance | - | - | $0 | $9,871,000 |
| Preferred Stock Issuance | - | - | $0 | $9,871,000 |
| Other | ||||
| Repayment Of Debt | $-88,409,000 | $-88,409,000 | $0 | $-29,396,000 |
| Issuance Of Debt | $88,480,000 | $88,480,000 | $30,953,000 | $48,469,000 |
| Interest Paid Supplemental Data | $8,035,000 | $8,035,000 | $3,476,000 | $1,321,000 |
| End Cash Position | $38,421,000 | $38,421,000 | $8,023,000 | $26,017,000 |
| Beginning Cash Position | $8,023,000 | $8,023,000 | $26,017,000 | $12,313,000 |
| Changes In Cash | $30,398,000 | $30,398,000 | $-17,994,000 | $13,704,000 |
| Proceeds From Stock Option Exercised | $213,000 | $213,000 | $132,000 | $523,000 |
| Net Issuance Payments Of Debt | $71,000 | $71,000 | $30,953,000 | $19,073,000 |
| Net Long Term Debt Issuance | $71,000 | $71,000 | $30,953,000 | $19,073,000 |
| Long Term Debt Payments | $-88,409,000 | $-88,409,000 | $0 | $-29,396,000 |
| Long Term Debt Issuance | $88,480,000 | $88,480,000 | $30,953,000 | $48,469,000 |
| Net PPE Purchase And Sale | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Purchase Of PPE | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Interest Paid Cfo | $-1,092,000 | $-1,092,000 | $0 | - |
| Change In Working Capital | $194,000 | $194,000 | $-13,788,000 | $-1,495,000 |
| Change In Other Current Liabilities | $-789,000 | $-789,000 | $-733,000 | $0 |
| Change In Payables And Accrued Expense | $5,721,000 | $5,721,000 | $11,489,000 | $2,086,000 |
| Change In Accrued Expense | $1,057,000 | $1,057,000 | $8,165,000 | $2,574,000 |
| Change In Payable | $4,664,000 | $4,664,000 | $3,324,000 | $-488,000 |
| Change In Account Payable | $4,664,000 | $4,664,000 | $3,324,000 | $-488,000 |
| Change In Prepaid Assets | $285,000 | $285,000 | $-577,000 | $-1,369,000 |
| Change In Inventory | $-3,705,000 | $-3,705,000 | $-1,150,000 | $-1,285,000 |
| Change In Receivables | $-1,318,000 | $-1,318,000 | $-22,817,000 | $-927,000 |
| Changes In Account Receivables | $-1,318,000 | $-1,318,000 | $-22,817,000 | $-927,000 |
| Other Non Cash Items | $-4,961,000 | $-4,961,000 | $2,057,000 | $-321,000 |
| Stock Based Compensation | $8,357,000 | $8,357,000 | $437,000 | $313,000 |
| Provisionand Write Offof Assets | $14,074,000 | $14,074,000 | $436,000 | $220,000 |
| Depreciation Amortization Depletion | $746,000 | $746,000 | $895,000 | $707,000 |
| Depreciation And Amortization | $746,000 | $746,000 | $895,000 | $707,000 |
| Depreciation | $746,000 | $746,000 | $895,000 | $707,000 |
| Gain Loss On Investment Securities | $-4,442,000 | $-6,634,000 | $839,000 | $240,000 |
| Net Foreign Currency Exchange Gain Loss | $-180,000 | $-180,000 | $-113,000 | - |
| Net Income From Continuing Operations | $-80,607,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Unrealized Gain Loss On Investment Securities | - | $4,402,000 | $0 | - |
Fetched: 2026-03-06